Trial Profile
Multicenter, Post-marketing, Non-interventional, Observational Study in RA Patients Treated With Tocilizumab.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Tocilizumab (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors Roche
- 19 Feb 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 21 Jul 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
- 03 Dec 2013 Planned number of patients changed from 200 to 300 as reported by ClinicalTrials.gov.